These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27623556)

  • 1. Identification of Novel Serum Autoantibodies for Differential Diagnosis of Autoimmune Pancreatitis and Pancreatic Ductal Adenocarcinoma.
    Felix K; Hauck O; Schnölzer M; Kempf T; Warnken U; Schneider K; Bergmann F; Fritz S; Werner J
    Pancreas; 2016 Oct; 45(9):1309-19. PubMed ID: 27623556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct pathophysiological cytokine profiles for discrimination between autoimmune pancreatitis, chronic pancreatitis, and pancreatic ductal adenocarcinoma.
    Ghassem-Zadeh S; Gaida MM; Szanyi S; Acha-Orbea H; Frossard JL; Hinz U; Hackert T; Strobel O; Felix K
    J Transl Med; 2017 Jun; 15(1):126. PubMed ID: 28578701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Autoantibody Signatures in Sera of Patients with Pancreatic Cancer, Chronic Pancreatitis and Autoimmune Pancreatitis: A Protein Microarray Profiling Approach.
    Ghassem-Zadeh S; Hufnagel K; Bauer A; Frossard JL; Yoshida M; Kutsumi H; Acha-Orbea H; Neulinger-Muñoz M; Vey J; Eckert C; Strobel O; Hoheisel JD; Felix K
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Diagnosis of Autoimmune Pancreatitis From Pancreatic Cancer by Analysis of Serum Gelatinase Levels.
    Felix K; Dobiasch S; Gaida MM; Schneider K; Werner J; Martens E; Vandooren J; Opdenakker G
    Pancreas; 2016 Aug; 45(7):1048-55. PubMed ID: 26692441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiating Mass-Forming Autoimmune Pancreatitis From Pancreatic Ductal Adenocarcinoma on the Basis of Contrast-Enhanced MRI and DWI Findings.
    Choi SY; Kim SH; Kang TW; Song KD; Park HJ; Choi YH
    AJR Am J Roentgenol; 2016 Feb; 206(2):291-300. PubMed ID: 26797355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of magnetic resonance elastography in differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma: A preliminary study.
    Shi Y; Cang L; Zhang X; Cai X; Wang X; Ji R; Wang M; Hong Y
    Eur J Radiol; 2018 Nov; 108():13-20. PubMed ID: 30396645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma with CT radiomics features.
    Park S; Chu LC; Hruban RH; Vogelstein B; Kinzler KW; Yuille AL; Fouladi DF; Shayesteh S; Ghandili S; Wolfgang CL; Burkhart R; He J; Fishman EK; Kawamoto S
    Diagn Interv Imaging; 2020 Sep; 101(9):555-564. PubMed ID: 32278586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific MAPK-Associated MicroRNAs in Serum Differentiate Pancreatic Cancer from Autoimmune Pancreatitis.
    Akamatsu M; Makino N; Ikeda Y; Matsuda A; Ito M; Kakizaki Y; Saito Y; Ishizawa T; Kobayashi T; Furukawa T; Ueno Y
    PLoS One; 2016; 11(7):e0158669. PubMed ID: 27380024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinguishing pancreatic cancer and autoimmune pancreatitis with in vivo tomoelastography.
    Zhu L; Guo J; Jin Z; Xue H; Dai M; Zhang W; Sun Z; Xu J; Marticorena Garcia SR; Asbach P; Hamm B; Sack I
    Eur Radiol; 2021 May; 31(5):3366-3374. PubMed ID: 33125553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic duct "Icicle sign" on MRI for distinguishing autoimmune pancreatitis from pancreatic ductal adenocarcinoma in the proximal pancreas.
    Kim HJ; Kim YK; Jeong WK; Lee WJ; Choi D
    Eur Radiol; 2015 Jun; 25(6):1551-60. PubMed ID: 25501271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic ductal adenocarcinoma with autoimmune pancreatitis-like histologic and immunohistochemical features.
    Zhang X; Liu X; Joseph L; Zhao L; Hart J; Xiao SY
    Hum Pathol; 2014 Mar; 45(3):621-7. PubMed ID: 24457081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High accuracy differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma by immunoglobulin G glycosylation.
    Shih HC; Chang MC; Chen CH; Tsai IL; Wang SY; Kuo YP; Chen CH; Chang YT
    Clin Proteomics; 2019; 16():1. PubMed ID: 30622446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilisation of artificial intelligence for the development of an EUS-convolutional neural network model trained to enhance the diagnosis of autoimmune pancreatitis.
    Marya NB; Powers PD; Chari ST; Gleeson FC; Leggett CL; Abu Dayyeh BK; Chandrasekhara V; Iyer PG; Majumder S; Pearson RK; Petersen BT; Rajan E; Sawas T; Storm AC; Vege SS; Chen S; Long Z; Hough DM; Mara K; Levy MJ
    Gut; 2021 Jul; 70(7):1335-1344. PubMed ID: 33028668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI features for differentiation of autoimmune pancreatitis from pancreatic ductal adenocarcinoma: A systematic review and meta-analysis.
    Ha J; Choi SH; Kim KW; Kim JH; Kim HJ
    Dig Liver Dis; 2022 Jul; 54(7):849-856. PubMed ID: 34903501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of autoimmune pancreatitis from pancreatic adenocarcinoma using CT characteristics: a systematic review and meta-analysis.
    Yoon SB; Jeon TY; Moon SH; Shin DW; Lee SM; Choi MH; Min JH; Kim MJ
    Eur Radiol; 2023 Dec; 33(12):9010-9021. PubMed ID: 37466708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and treatment of autoimmune pancreatitis types 1 and 2.
    Fritz S; Bergmann F; Grenacher L; Sgroi M; Hinz U; Hackert T; Büchler MW; Werner J
    Br J Surg; 2014 Sep; 101(10):1257-65. PubMed ID: 25047016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of CT and MRI for differentiation of autoimmune pancreatitis from pancreatic adenocarcinoma.
    Ha J; Choi SH; Byun JH; Kim KW; Kim SY; Kim JH; Kim HJ
    Eur Radiol; 2021 May; 31(5):3427-3438. PubMed ID: 33146798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodel magnetic resonance imaging of mass-forming autoimmune pancreatitis: differential diagnosis with pancreatic ductal adenocarcinoma.
    Jia H; Li J; Huang W; Lin G
    BMC Med Imaging; 2021 Oct; 21(1):149. PubMed ID: 34654379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discriminating patients with early-stage pancreatic cancer or chronic pancreatitis using serum electrospray mass profiling.
    Hocker JR; Postier RG; Li M; Lerner MR; Lightfoot SA; Peyton MD; Deb SJ; Baker CM; Williams TL; Hanas RJ; Stowell DE; Lander TJ; Brackett DJ; Hanas JS
    Cancer Lett; 2015 Apr; 359(2):314-24. PubMed ID: 25637792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase diagnostic accuracy in differentiating focal type autoimmune pancreatitis from pancreatic cancer with combined serum IgG4 and CA19-9 levels.
    Chang MC; Liang PC; Jan S; Yang CY; Tien YW; Wei SC; Wong JM; Chang YT
    Pancreatology; 2014; 14(5):366-72. PubMed ID: 25278306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.